ECS BOTANICS HOLDINGS LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.022 AUD | 0.00% |
|
+4.76% | -2.22% |
| 02-27 | ECS Botanics Holdings Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| 02-01 | ECS Botanics Secures AU$9.3 Million Offtake Deal; Shares Up 4% | MT |
| Sales 2022 | 7.18M 4.72M 376M | Sales 2023 | 15.39M 10.12M 807M | Capitalization | 27.67M 18.19M 1.45B |
|---|---|---|---|---|---|
| Net income 2022 | -1M -657K -52.42M | Net income 2023 | - 0 0 | EV / Sales 2022 | 2.36 x |
| Net cash position 2022 | 1.85M 1.21M 96.81M | Net cash position 2023 | 2.21M 1.45M 116M | EV / Sales 2023 | 1.65 x |
| P/E ratio 2022 |
-15.5
x | P/E ratio 2023 |
-205
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.05% |
More Fundamentals
* Assessed data
More news
| 1 week | +4.76% | ||
| Current month | -12.00% | ||
| 1 month | -8.33% | ||
| 6 months | -4.35% | ||
| Current year | -2.22% |
1 week
0.02
0.02
1 month
0.020.03
Current year
0.020.03
1 year
0.020.03
3 years
0.010.05
5 years
0.010.09
10 years
0.010.09
| Managers | Title | Age | Since |
|---|---|---|---|
Alexander Keach
FOU | Founder | - | 20/02/70 |
| Chief Executive Officer | - | 14/03/21 | |
Arthur Sun
DFI | Director of Finance/CFO | - | 30/04/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jeremy King
CHM | Chairman | 50 | 10/01/17 |
| Chief Executive Officer | - | 14/03/21 | |
Alexander Keach
FOU | Founder | - | 20/02/70 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 0.022 | 0.00% | 8 377 192 |
| 26/04/24 | 0.022 | 0.00% | 863,208 |
| 24/04/24 | 0.022 | +4.76% | 816,045 |
| 23/04/24 | 0.021 | 0.00% | 400,051 |
| 22/04/24 | 0.021 | -4.55% | 610,245 |
Delayed Quote Australian S.E., April 29, 2024 at 05:51 am
More quotes
ECS Botanics Holdings Ltd is an Australia-based medicinal cannabis company. The Company is engaged in the cultivation and manufacturing of good manufacturing practice (GMP) medicinal cannabis with a facility in Northwest Victoria. The Company operates through two segments: ECS Botanics Pty Ltd, and Murray Meds Pty Ltd and Flowerday Farms Pty Ltd. ECS Botanics Pty Ltd is engaged in the sale of food and wellness products. Murray Meds Pty Ltd and Flowerday Farms Pty Ltd are engaged in the sale of medicinal cannabis plant-related products. It cultivates a range of strains for extraction and inhalation. The Company extracts resin from its strains for the formulation of oils and other products.
Calendar
28/08/2024
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.22% | 18.49M | |
| +31.96% | 272M | |
| +33.74% | 261M | |
| +49.42% | 194M | |
| +44.98% | 131M | |
| -28.57% | 121M | |
| +115.91% | 119M | |
| -42.17% | 119M | |
| 0.00% | 86.82M | |
| +150.00% | 75.33M |
- Stock Market
- Equities
- ECS Stock
